-10.0%
BA vs MRNA
+455.8%
-465.8%
-25.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.8% | +0.7% | -1.5% | -0.8% |
| 7D | -2.7% | -8.2% | +5.5% | -2.6% |
| 30D | -12.2% | +125.6% | -137.8% | -14.1% |
| 3M | -2.0% | +197.1% | -199.1% | -6.6% |
| 6M | -6.0% | +148.5% | -154.4% | -9.6% |
| YTD | -5.7% | +363.3% | -368.9% | -11.0% |
| 1Y | -10.0% | +462.0% | -472.0% | -13.1% |
| All | -10.0% | +455.8% | -465.8% | -13.1% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling